Pharmaceutical Executive December 8, 2021
Matthew W. Reynolds, PhD

Practices to ensure accuracy in selected datasets.

Real world data (RWD) has been used for more than four decades to expand knowledge about a variety of research questions in healthcare—from disease epidemiology to the performance of treatments and devices in real world settings. This data can play a definitive role in generating evidence, provided the data sources are thoroughly vetted, fit-for-purpose, and the datasets match both the specific research question and the specific regulatory need.

In September and October, FDA issued new guidance about assessing electronic health record (EHR) and claims data and data standards for submissions containing RWD. This action shows the agency’s growing recognition of the value of leveraging RWD to gain insights into the safety, effectiveness, and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, EMR / EHR, FDA, Govt Agencies, Health IT, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Technology
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
Early tests of H5N1 prevalence in milk suggest U.S. bird flu outbreak in cows is widespread
Bird Flu (H5N1) Explained: Here’s What To Know—And Why Scientists Are Concerned
2023 Had Most Food Recalls Since Start Of COVID-19 Pandemic, Report Finds
Exo adds FDA-cleared AI tools to handheld ultrasound system

Share This Article